Gilbert & Cook’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Gilbert & Cook’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28,690	Closed	-$172K	–	222
2022 Q4	$172K	Hold	28,690	–	–	0.03%	201
2022 Q3	$144K	Sell	28,690 -500	-2%	-$3.12K	0.03%	202
2022 Q2	$174K	Hold	29,190	–	–	0.03%	195
2022 Q1	$136K	Hold	29,190	–	–	0.02%	202
2021 Q4	$72K	Buy	+29,190	New	+$71.4K	0.01%	206

Other funds holding CTIC

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Gilbert & Cook's CTIC Position: Q1 2023 in Review

Gilbert & Cook sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2023, closing a stake of 28,690 shares — an estimated $172K sold.

Gilbert & Cook first reported a position in CTIC in Q4 2021 and held it in 5 quarters. The position peaked at $174K in Q2 2022. 133 funds tracked by Wall St. Rank hold CTIC as of Q1 2023.

Gilbert & Cook reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2023 after selling out during the quarter.
Gilbert & Cook sold 28,690 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2023, an estimated $172K.
Gilbert & Cook first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2021 and held it in 5 quarters.
Gilbert & Cook's CTI BioPharma Corp. (DE) Common Stock position peaked at $174K in Q2 2022.
133 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2023.

Based on Gilbert & Cook's 13F filing for Q1 2023, filed 5 May 2023.